Filing Details
- Accession Number:
- 0000899243-20-012163
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-06 19:07:36
- Reporting Period:
- 2020-05-04
- Accepted Time:
- 2020-05-06 19:07:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1552451 | Myokardia Inc. | MYOK | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1413822 | Anastasios Gianakakos | C/O Myokardia, Inc. 1000 Sierra Point Parkway Brisbane CA 94005 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-05-04 | 1,386 | $56.93 | 77,736 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-04 | 400 | $58.05 | 77,336 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-04 | 2,909 | $59.10 | 74,427 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-04 | 305 | $60.15 | 74,122 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 130,407 | Indirect | By Reporting Person's Trust 2 |
| Common Stock | 300,000 | Indirect | By Reporting Person's Trust 4 |
| Common Stock | 6,000 | Indirect | By Reporting Person's Trust 5 |
| Common Stock | 53,087 | Indirect | By Trust 1 |
| Common Stock | 53,087 | Indirect | By Trust 2 |
| Common Stock | 53,087 | Indirect | By Trust 3 |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Represents the weighted average sale price of the shares sold ranging from $56.46 to $57.35 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges reported in footnotes 2, 4, 5 and 6.
- Includes 95,540 shares previously held by The TKG Trust dated November 2, 2006 which were contributed to the Reporting Person directly on May 1, 2020, and excludes (a) 300,000 shares previously owned directly which were contributed to The Tassos Gianakakos 2020 Annuity Trust on May 1, 2020 and (b) 6,000 shares previously owned directly which were contributed to The TKG 2020 Irrevocable Trust on May 1, 2020.
- Represents the weighted average price of the shares sold ranging from $57.48 to $58.40 per share.
- Represents the weighted average price of the shares sold ranging from $58.60 to $59.45 per share.
- Represents the weighted average price of the shares sold ranging from $59.67 to $60.17 per share.
- Excludes 95,540 shares previously held by The TKG Trust dated November 2, 2006 which were contributed to the Reporting Person directly on May 1, 2020.
- Includes 300,000 shares previously owned directly which were contributed to The Tassos Gianakakos 2020 Annuity Trust on May 1, 2020.
- Includes 6,000 shares previously owned directly which were contributed to The TKG 2020 Irrevocable Trust on May 1, 2020.
Billionaire Hedge Funds
